Literature DB >> 9289550

[Infection by Strongyloides stercoralis in the county of Safor, Spain].

M J Cremades Romero1, R Igual Adell, C Ricart Olmos, F Estellés Piera, A Pastor-Guzmán, R Menéndez Villanueva.   

Abstract

BACKGROUND: Strongyloides stercoralis is an endemic nematode in tropical and subtropical regions, but almost unknown in Spain. PATIENTS AND METHODS: In order to know some epidemiological, clinical and analytic features of this infection in our area (La Safor, Valencia), we performed a prospective study for 19 months. Through the search for the parasite in feces of patients with eosinophilia, we identified 37 subjects who were studied at diagnosis and 4 months later.
RESULTS: Thirty-three patients (89%) were currently, or had been agricultural workers, and thirty had worked barefooted and/or had drunk contaminated irrigation water. Twenty-three patients (62%) had a chronic or immunosuppressive diseases, and two of them on steroid treatment, developed a disseminated strongyloidiasis. Thirteen patients (35%) were asymptomatic; the rest had clinical manifestations attributed S. stercoralis, mainly digestive. Two of the patients with disseminated strongyloidiasis also had concomitant bacterial infections by Streptococcus bovis, Streptococcus faecalis and Enterobacter sp. At diagnosis, besides eosinophilia, 86.5% had raised levels of IgE. Four months later treatment, the number of eosinophils was normal and IgE levels significantly decreased. The diagnostic yield of parasitic study of feces was increased with the number of samples examined. Thiabendazole achieved erradication of the parasite in 35 patients, and the other two died because of disseminated strongyloidiasis.
CONCLUSIONS: The presence of eosinophilia in patients from rural areas with subtropical climate should raise suspicion about infection by S. stercoralis, which, although sometimes is asymptomatic, may cause systemic bacterial infections in cases of hyperinfestation, specially when glucocorticoid treatment is given.

Entities:  

Mesh:

Year:  1997        PMID: 9289550

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  6 in total

1.  Strongyloides stercolaris infection mimicking a malignant tumour in a non-immunocompromised patient. Diagnosis by bronchoalveolar cytology.

Authors:  E Mayayo; V Gomez-Aracil; J Azua-Blanco; J Azua-Romeo; J Capilla; R Mayayo
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

2.  A retrospective study of autochthonous strongyloïdiasis in Région Midi-Pyrénées (Southwestern France).

Authors:  J F Magnaval; J M Mansuy; L Villeneuve; S Cassaing
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

3.  Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.

Authors:  Tatvam T Choksi; Gul Madison; Tawseef Dar; Mohammed Asif; Kevin Fleming; Leon Clarke; Mervyn Danilewitz; Randa Hennawy
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

4.  Morbidity Associated with Chronic Strongyloides stercoralis Infection: A Systematic Review and Meta-Analysis.

Authors:  Francesca Tamarozzi; Elisa Martello; Giovanni Giorli; Andrea Fittipaldo; Silvia Staffolani; Antonio Montresor; Zeno Bisoffi; Dora Buonfrate
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

5.  Intestinal strongyloidiasis and hyperinfection syndrome.

Authors:  Raja S Vadlamudi; David S Chi; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2006-05-30

6.  Strongyloides stercoralis infection: A systematic review of endemic cases in Spain.

Authors:  Maria Barroso; Fernando Salvador; Adrián Sánchez-Montalvá; Pau Bosch-Nicolau; Israel Molina
Journal:  PLoS Negl Trop Dis       Date:  2019-03-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.